Loncar Debuts ETF to Play China’s Biotech, Pharma Companies

Loncar Investments has partnered up with Exchange Traded Concepts to launch a new ETF that tracks the growing biopharmaceutical sector in China. On Wednesday, Loncar Investments rolled out the Loncar China BioPharma ETF (NasdaqGM: CHNA), which has a 0.79% expense ratio. “China aims to become a...